Resultado da Busca
Recognising the urgent need to find a treatment for patients with triplet repeat expansion diseases, LoQus23 Therapeutics was co-founded in 2019 by David Reynolds, CEO and Caroline Benn, CSO when they were entrepreneurs in residence at the Dementia Discovery Fund.
Caroline Middleton Benn (née DeCamp; 13 October 1926 – 22 November 2000), formerly Viscountess Stansgate, was an educationalist and writer, and wife of the British Labour politician Tony Benn (formerly 2nd Viscount Stansgate).
Proceedings of the National Academy of Sciences 111 (35), 12853-12858. , 2014. 169. 2014. SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease. M Mielcarek, CL Benn, SA Franklin, DL Smith, B Woodman, PA Marks, ...
Caroline Benn is the CSO of LoQus23 Therapeutics, Cambridge, UK. Caroline is a molecular and cellular neuroscientist with research expertise in Huntington's disease and drug discovery.
Caroline Ben (@carolbenn) • Instagram photos and videos. 1,399 Followers, 318 Following, 117 Posts - Caroline Ben (@carolbenn) on Instagram: "📍Portugal 🇵🇹 📱👩🏻💻 | 👩🏻🏭🔥".
- 1402
Post-Doctorate. Executive (VP, SVP, CFO, CTO etc.) Primary. LoQus23 Therapeutics. Cambridge, United Kingdom. Other. Cambridge, United Kingdom. Caroline Benn. Overview.
24 de nov. de 2000 · Caroline Benn, who has died aged 74, achieved the extraordinary feat of securing an independent academic status for her work in education while winning widespread political admiration for the...
